256 related articles for article (PubMed ID: 27254284)
1. Knockdown of GRP78 enhances cell death by cisplatin and radiotherapy in nasopharyngeal cells.
Huang YY; Pu LJ; Song LL; Ma LY; Liu H; Jiang CC
Anticancer Drugs; 2016 Sep; 27(8):726-33. PubMed ID: 27254284
[TBL] [Abstract][Full Text] [Related]
2. Triptolide Induces Apoptosis and Synergizes with Cisplatin in Cisplatin-Resistant HNE1/DDP Nasopharyngeal Cancer Cells.
Wang X; Zhang JJ; Sun YM; Zhang J; Wang LR; Li JC; Liu H
Folia Biol (Praha); 2015; 61(5):195-202. PubMed ID: 26667576
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of Autophagy Potentiated the Antitumor Effect of Nedaplatin in Cisplatin-Resistant Nasopharyngeal Carcinoma Cells.
Liu Z; Liu J; Li L; Nie D; Tao Q; Wu J; Fan J; Lin C; Zhao S; Ju D
PLoS One; 2015; 10(8):e0135236. PubMed ID: 26288183
[TBL] [Abstract][Full Text] [Related]
4. Epithelial-mesenchymal transition is necessary for acquired resistance to cisplatin and increases the metastatic potential of nasopharyngeal carcinoma cells.
Zhang P; Liu H; Xia F; Zhang QW; Zhang YY; Zhao Q; Chao ZH; Jiang ZW; Jiang CC
Int J Mol Med; 2014 Jan; 33(1):151-9. PubMed ID: 24173500
[TBL] [Abstract][Full Text] [Related]
5. [Long non-coding RNA XIST modulates cisplatin resistance by altering PDCD4 and Fas-Lexpressions in human nasopharyngeal carcinoma HNE1 cells
Wang H; Li W; Tan G
Nan Fang Yi Ke Da Xue Xue Bao; 2019 Mar; 39(3):357-363. PubMed ID: 31068307
[TBL] [Abstract][Full Text] [Related]
6. Positive regulation of ataxia-telangiectasia-mutated protein (ATM) by E2F transcription Factor 1 (E2F-1) in cisplatin-resistant nasopharyngeal carcinoma cells.
Zhou ZY; Yang JY; Shao CZ; Luo F; Du W
World J Surg Oncol; 2022 Mar; 20(1):88. PubMed ID: 35303867
[TBL] [Abstract][Full Text] [Related]
7. Cisplatin combined with metformin inhibits migration and invasion of human nasopharyngeal carcinoma cells by regulating E-cadherin and MMP-9.
Sun XJ; Zhang P; Li HH; Jiang ZW; Jiang CC; Liu H
Asian Pac J Cancer Prev; 2014; 15(9):4019-23. PubMed ID: 24935589
[TBL] [Abstract][Full Text] [Related]
8. MiR-183 overexpression inhibits tumorigenesis and enhances DDP-induced cytotoxicity by targeting MTA1 in nasopharyngeal carcinoma.
Wang G; Wang S; Li C
Tumour Biol; 2017 Jun; 39(6):1010428317703825. PubMed ID: 28631568
[TBL] [Abstract][Full Text] [Related]
9. [Autophagy inhibitor 3-methyladenine enhances the sensitivity of nasopharyngeal carcinoma cells to chemotherapy and radiotherapy].
Song L; Ma L; Chen G; Huang Y; Sun X; Jiang C; Liu H
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2016 Jan; 41(1):9-18. PubMed ID: 26819419
[TBL] [Abstract][Full Text] [Related]
10. [Combination of cytosine arabinoside and cisplatin enhances inhibition of cell proliferation and promotes apoptosis of resistant nasopharyngeal carcinoma cells].
Chen J; Liu S; Li Q; Peng J
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2015 Mar; 31(3):379-82, 386. PubMed ID: 25744845
[TBL] [Abstract][Full Text] [Related]
11. Long Noncoding RNA HOXA11-AS Modulates the Resistance of Nasopharyngeal Carcinoma Cells to Cisplatin via miR-454-3p/c-Met.
Lin FJ; Lin XD; Xu LY; Zhu SQ
Mol Cells; 2020 Oct; 43(10):856-869. PubMed ID: 33115978
[TBL] [Abstract][Full Text] [Related]
12. miR‑495 enhances the efficacy of radiotherapy by targeting GRP78 to regulate EMT in nasopharyngeal carcinoma cells.
Feng X; Lv W; Wang S; He Q
Oncol Rep; 2018 Sep; 40(3):1223-1232. PubMed ID: 30015969
[TBL] [Abstract][Full Text] [Related]
13. Downregulation of glucose-regulated protein 78 enhances the cytotoxic effects of curcumin on human nasopharyngeal carcinoma cells.
Yu X; Shi L; Yan L; Wang H; Wen Y; Zhang X
Int J Mol Med; 2018 Nov; 42(5):2943-2951. PubMed ID: 30226563
[TBL] [Abstract][Full Text] [Related]
14. Synergistic effects of autophagy inhibitors combined with cisplatin against cisplatin-resistant nasopharyngeal cancer cells.
Yin W; Xu J; Mao Y
Biochem Cell Biol; 2021 Jun; 99(3):322-329. PubMed ID: 34038188
[TBL] [Abstract][Full Text] [Related]
15. SATB1 Knockdown Inhibits Proliferation and Invasion and Decreases Chemoradiation Resistance in Nasopharyngeal Carcinoma Cells by Reversing EMT and Suppressing MMP-9.
Zhou D; Ye C; Pan Z; Deng Y
Int J Med Sci; 2021; 18(1):42-52. PubMed ID: 33390772
[No Abstract] [Full Text] [Related]
16. Knockdown of USP9X reverses cisplatin resistance by decreasing β-catenin expression in nasopharyngeal carcinoma cells.
Lu WX; Gan GS; Yang B
Neoplasma; 2021 Jul; 68(4):810-822. PubMed ID: 34097426
[TBL] [Abstract][Full Text] [Related]
17. [miR-129-1-3p reverses cisplatin resistance of HNE1/CDDP human nasopharyngeal carcinoma cells by targeting inhibition of WEE1 kinase].
Zhang H; Lu J; Jiang C; Lu W
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2019 Nov; 35(11):1014-1019. PubMed ID: 31878998
[TBL] [Abstract][Full Text] [Related]
18. MicroRNA-139-5p affects cisplatin sensitivity in human nasopharyngeal carcinoma cells by regulating the epithelial-to-mesenchymal transition.
Shao Q; Zhang P; Ma Y; Lu Z; Meng J; Li H; Wang X; Chen D; Zhang M; Han Y; Liu H; Ma S
Gene; 2018 Apr; 652():48-58. PubMed ID: 29427737
[TBL] [Abstract][Full Text] [Related]
19. NEDD4 is involved in acquisition of epithelial-mesenchymal transition in cisplatin-resistant nasopharyngeal carcinoma cells.
Feng S; Yang G; Yang H; Liang Z; Zhang R; Fan Y; Zhang G
Cell Cycle; 2017 May; 16(9):869-878. PubMed ID: 28379054
[TBL] [Abstract][Full Text] [Related]
20. Exosomal ERp44 derived from ER-stressed cells strengthens cisplatin resistance of nasopharyngeal carcinoma.
Xia T; Tian H; Zhang K; Zhang S; Chen W; Shi S; You Y
BMC Cancer; 2021 Sep; 21(1):1003. PubMed ID: 34493236
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
